Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Global Survey Underscores Need to Standardize Bone Biomarker Testing

By LabMedica International staff writers
Posted on 01 Oct 2026

Bone and mineral metabolism biomarkers can complement dual-energy X-ray absorptiometry (DXA) by providing information on disease activity and treatment response. More...

For more than 20 years, standardization of nomenclature, abbreviations, and units has remained an issue for bone status indices (BSIs). Now, a new study shows substantial international variability in BSI laboratory testing practices.

The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Joint Committee on Bone Metabolism examined self-reported laboratory practices for blood-based bone status index (BSI) testing. The study, titled IOF-IFCC International Survey of Global Laboratory Practices for Bone Status Indices, assessed how laboratories measure, report, and interpret biomarkers of bone and mineral metabolism. The analysis revealed variation in analytical platforms, instruments, specimen types, reporting units, reference intervals, decision thresholds, participation in external quality assessment (EQA) programs, and reimbursement practices.

The study collected 231 responses from laboratories in 41 countries and found substantial variation in reference intervals, including among laboratories using the same manufacturer and instrument. Participation in external quality assessment appeared high for total alkaline phosphatase (ALP) and parathyroid hormone (PTH), but lower for β-isomerized C-terminal telopeptide of type I collagen (β-CTX-I) and procollagen type I N-propeptide (PINP). Adoption of β-CTX-I and PINP testing also remained incomplete, although use appeared more common in laboratories monitoring patients with osteoporosis.

The findings further showed limited access to bone-specific ALP and tartrate-resistant acid phosphatase 5b (TRAP5b). PTH testing showed poor harmonization, largely because second- and third-generation assays are used concurrently. Vitamin D decision thresholds also varied widely, and laboratories frequently reported inappropriate ordering of 1,25(OH)₂D to assess vitamin D status instead of 25(OH)D. The study was published on August 7, 2026, in Clinical Chemistry and Laboratory Medicine.

“The survey's findings reveal the extent of variation in laboratory practices that can affect BSI test results. These findings show that the lack of harmonization is not merely a laboratory issue. When the same biomarker is measured, reported or interpreted differently across laboratories, this limits the comparability of research data and can ultimately affect clinical decision-making. Greater harmonization is therefore essential if these biomarkers are to reach their full clinical potential,” said Professor Etienne Cavalier of the University of Liège in Belgium, chair representing IOF on the IOF–IFCC Joint Committee on Bone Metabolism and corresponding author.

Related Links
IOF
IFCC


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.